FHTX vs MELI · rev $19.3M vs P/E 43, rev $19.01B
Foghorn Therapeutics Inc (FHTX) versus MercadoLibre Inc. (MELI) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Latest reported FHTX revenue for 2026-06-30 was $19.3M. Net income was -$27.1M. FHTX currently screens at market cap $237.8M.
Latest reported MELI revenue for 2026-06-30 was $19.01B. Net income was $883.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
FHTX currently screens at market cap $237.8M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Not investment advice. Open the FHTX and MELI stock pages for the full models.
Not investment advice.